FDA Strengthens Warnings on Gardasil
Links shared publicly online about this topic
FDA Strengthens Warnings on Gardasil - WSJ.com
online.wsj.com — “The FDA strengthened warnings on Merck's Gardasil vaccine about fainting after receiving reports of traumatic injuries among some vaccine recipients.” View full resource at online.wsj.com
Most Recently Shared on June 10, 2009 at 9:33 pm By:
FDA Strengthens Warnings on Gardasil http://tinyurl.com/m75uhh
FDA Strengthens Warnings on Gardasil - WSJ.com
online.wsj.com — “The FDA strengthened warnings on Merck's Gardasil vaccine about fainting after receiving reports of traumatic injuries among some vaccine recipients.” View full resource at online.wsj.com
Most Recently Shared on June 11, 2009 at 4:52 pm By:
Terri Schmitt Nurse and Advanced Practice Nurse
FDA serious about watching girls for fainting after gardasil vaccine. http://alturl.com/hqts
FDA strengthens labeling for HPV vaccine | HemOncToday
hemonctoday.com — “The FDA has is urging physicians to administer Merck’s Gardasil vaccine while a patient is seated or lying down and is asking that patients” View full resource at hemonctoday.com
Most Recently Shared on June 16, 2009 at 5:48 pm By:
HemOnc Today Oncology and Health News
Fainting reported after HPV vaccine. FDA strengthens label. #Gardasil http://bit.ly/Q9eU5
FDA Strengthens Topamax Warning - WSJ.com
online.wsj.com — “The FDA will strengthen warnings on J&J's antiseizure treatment Topamax and its generic equivalents after new data suggested a higher risk for cleft palates in babies born to women taking the drug.” View full resource at online.wsj.com
Most Recently Shared on March 4, 2011 at 11:18 pm By:
FDA Strengthens Topamax Warning: The FDA will strengthen warnings on J&J's anti-migraine treatment Topamax and i... http://bit.ly/fYqIb2
FDA Strengthens Gadolinium Warnings : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on September 9, 2010 at 9:35 pm By:
Skin & Allergy News Health News
FDA Strengthens Gadolinium Warnings http://bit.ly/cLenR3
FDA strengthens Plavix safety warning | InPharm
inpharm.com — “FDA strengthens Plavix safety warning | InPharm” View full resource at inpharm.com
Most Recently Shared on March 15, 2010 at 12:31 pm By:
Pharmafocus Health News and Pharma
FDA strengthens Plavix safety warning - A boxed warning has been added to the US packaging of Sanofi-Aventis and Br... http://ow.ly/16O5cq
FDA Strengthens Kaletra Warning for Use in Premature Infants - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals of serious health problems that have been reported in premature babies receiving Kaletra (lopinavir/ritonavir oral solution; Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 8, 2011 at 5:42 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA Strengthens Kaletra Warning for Use in Premature Infants http://goo.gl/fb/AhT4C
FDA Strengthens Kaletra Warning for Use in Premature Infants - MPR
empr.com — “The FDA has notified healthcare professionals of serious health problems that have been reported in premature babies receiving Kaletra (lopinavir/ritonavir oral solution; Abbott).” View full resource at empr.com
Most Recently Shared on March 8, 2011 at 5:46 pm By:
MPR News: FDA Strengthens Kaletra Warning for Use in Premature Infants: The FDA has notified healthcare professi... http://bit.ly/fb3wP4
FDA warns of fractures with osteoporosis drugs
health.yahoo.net — “Government health officials warned doctors and patients Wednesday about an increased risk of thigh bone fractures with a widely-used group of bone-strengthening drugs.” View full resource at health.yahoo.net
Most Recently Shared on October 13, 2010 at 6:04 pm By:
RT @health_tweets: FDA warns of fractures w/ osteoporosis drugs... http://dld.bz/zxBM #health
Medical News: FDA Strengthens Warning on Transplant Drug - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- A warning of a risk of pure red cell aplasia (PRCA) has been added to the label and prescribing information for mycophenolate mofetil (CellCept).” View full resource at medpagetoday.com
Most Recently Shared on August 15, 2009 at 3:33 am By:
FDA Strengthens Warning on Transplant Drug http://ow.ly/15L6sz
3rd UPDATE: FDA Strengthens Topamax Warning On Birth Defects Data - WSJ.com
online.wsj.com — “3rd UPDATE: FDA Strengthens Topamax Warning On Birth Defects Data - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on March 7, 2011 at 6:39 pm By:
Nancy M. Silva, MD Doctor, Pediatrician, and Physician
FDA: Anti-seizure drug Topamax may raise risk of oral clefts http://on.wsj.com/eWEBdN
FDA adds warning labels to bone-strengthening drugs about risks of thigh bone fractures | StarTribune.com
startribune.com — “FDA adds warning labels to bone-strengthening drugs about risks of thigh bone fractures | StarTribune.com” View full resource at startribune.com
Most Recently Shared on October 13, 2010 at 6:36 pm By:
FDA adds warning labels to bone-strengthening drugs about risks of thigh bone fractures: http://bit.ly/dAd5Qa
More Studies Are Needed After FDA Issues Warning About Bisphosphonates Therapy
medicalnewstoday.com — “On October 13, the Food and Drug Administration published a warning to doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs called b” View full resource at medicalnewstoday.com
Most Recently Shared on October 20, 2010 at 2:05 pm By:
MNT Bones/Orthopedic Health News
More Studies Are Needed After FDA Issues Warning About Bisphosphonates Therapy http://mnt.to/3Lsc #bones #orthopedics
Osteoporosis Drugs Could Increase Risk Of Fractures, Warns FDA
huffingtonpost.com — “WASHINGTON — Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs. The Food and Drug Administration said patients taking bisphosphonate drugs such as Fosamax and Boniva appear more likely to suffer a rare type of fracture of the femur.” View full resource at huffingtonpost.com
Most Recently Shared on October 14, 2010 at 4:15 pm By:
Jeffrey Gladd, MD Physician, Doctor, CAM, Family Medicine Doctor, and Integrative Physician
Government health officials warned doctors and patients Wednesday about an increased risk of thigh fractures with... http://fb.me/K5S1ZZrR
Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to strengthen warnings - MPR
empr.com — “The FDA has notified healthcare professionals that it is requiring the manufacturers of licensed botulinum toxin products, including Botox and Botox Cosmetic (botulinum toxin type A, from Allergan) and Myobloc (botulinum toxin type B, from Solstice Neurosciences), to strengthen warnings in product labeling and add a boxed warning regarding the risk of adverse events when the effects of the toxin spreads beyond the injection site.” View full resource at empr.com
Most Recently Shared on April 30, 2009 at 8:05 pm By:
MPR News: Manufacturers of botulinum toxin products (Botox, Botox Cosmetic, Myobloc) required to streng.. http://tinyurl.com/c674rf
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
WSJ Health
Health news coverage from the Wall Street Journal
-
Terri Schmitt
Spreading the important word about how Nursing can change Health Care. Faculty, NP, and student myself.
-
HemOnc Today
The official Twitter feed for HemOnc Today, offering news and perspectives in hematology and oncology.
Advertisement
